Long- term remission status in pediatric obsessive-compulsive disorder: Evaluating the predictive value of symptom severity after treatment

•Treatment effects are mainly evaluated on the basis of posttreatment symptoms.•Obsessive-compulsive disorder (OCD) usually presents with fluctuating symptoms.•Posttreatment symptoms in pediatric OCD does not predict long-term remission status. It is unknown if long-term remission for pediatric obse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry research 2022-11, Vol.317, p.114906-114906, Article 114906
Hauptverfasser: Jensen, Sanne, Mortensen, Erik L., Skarphedinsson, Gudmundur, Højgaard, David RMA, Hybel, Katja A., Nissen, Judith B., Tord Ivarsson, Weidle, Bernhard, Torp, Nor C., Thomsen, Per H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Treatment effects are mainly evaluated on the basis of posttreatment symptoms.•Obsessive-compulsive disorder (OCD) usually presents with fluctuating symptoms.•Posttreatment symptoms in pediatric OCD does not predict long-term remission status. It is unknown if long-term remission for pediatric obsessive-compulsive disorder (OCD) patients is associated with post-treatment OCD symptom severity. The aim of the present study was to evaluate if post-treatment symptom severity cut-offs can discriminate remitters from non-remitters in pediatric OCD patients during three years of follow-up. All participants (N = 269) from the Nordic Long-term OCD Treatment Study (NordLOTS) undergoing stepped-care treatment were included. Patients were rated with the Clinical Global Impression – Severity Scale (CGI-S) one (n = 186), two (n = 167), and three years (n = 166) after first-line cognitive-behavioral therapy. Post-treatment symptom severity scores as well as percentage reductions during treatment evaluated with the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) were analyzed using receiver operating characteristics according to the CGI-S remission scores (< 2) at follow-up. Post-treatment CY-BOCS severity scores acceptably discriminated remitters from non-remitters at one-year follow-up, but poorly for the two- and three-year follow-up. Severity percentage reduction during treatment did not discriminate remission status acceptably at any follow-up point. Post-treatment OCD symptom severity status seems to have little discriminative value for long-term remission status in pediatric patients. Further research is warranted to detect post-treatment factors of prognostic value.
ISSN:0165-1781
1872-7123
DOI:10.1016/j.psychres.2022.114906